In vitro and in vivo neurotoxicity of prion protein oligomers
2007

Neurotoxicity of Prion Protein Oligomers

publication Evidence: high

Author Information

Author(s): Simoneau Steve, Rezaei Human, Salès Nicole, Kaiser-Schulz Gunnar, Lefebvre-Roque Maxime, Vidal Catherine, Fournier Jean-Guy, Comte Julien, Wopfner Franziska, Grosclaude Jeanne, Schätzl Hermann, Lasmézas Corinne Ida

Primary Institution: Commissariat à l'Energie Atomique, Fontenay-aux-Roses, France

Hypothesis

Do prion protein oligomers cause neurotoxicity in vitro and in vivo?

Conclusion

Prion protein oligomers are highly neurotoxic, while larger fibrillar forms are not.

Supporting Evidence

  • PrP oligomers were shown to be neurotoxic in both in vitro and in vivo models.
  • Monomeric PrP was not toxic, while oligomeric forms caused significant neuronal death.
  • Blocking the hydrophobic domain of PrP oligomers prevented their neurotoxic effects.
  • PrP fibrils exhibited much lower toxicity compared to oligomers.
  • The study suggests that prion diseases share mechanisms with other neurodegenerative diseases.

Takeaway

Small clumps of a protein called prion can kill brain cells, but bigger clumps don't hurt them.

Methodology

The study involved in vitro tests on primary neuron cultures and in vivo tests using mouse models with different forms of prion proteins injected into their brains.

Limitations

The study primarily focused on specific types of prion proteins and may not generalize to all prion diseases.

Participant Demographics

Mice used included wild-type C57BL/6 and PrP knockout strains.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.ppat.0030125

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication